Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 148


Tuberculin skin test versus interferon-gamma release assays for the diagnosis of tuberculosis infection.

De Keyser E, De Keyser F, De Baets F.

Acta Clin Belg. 2014 Oct;69(5):358-66. doi: 10.1179/2295333714Y.0000000043. Epub 2014 Jul 14.


Interferon-gamma release assay for the diagnosis of latent tuberculosis infection: A latent-class analysis.

Doan TN, Eisen DP, Rose MT, Slack A, Stearnes G, McBryde ES.

PLoS One. 2017 Nov 28;12(11):e0188631. doi: 10.1371/journal.pone.0188631. eCollection 2017.


Accurate diagnosis of latent tuberculosis in children, people who are immunocompromised or at risk from immunosuppression and recent arrivals from countries with a high incidence of tuberculosis: systematic review and economic evaluation.

Auguste P, Tsertsvadze A, Pink J, Court R, Seedat F, Gurung T, Freeman K, Taylor-Phillips S, Walker C, Madan J, Kandala NB, Clarke A, Sutcliffe P.

Health Technol Assess. 2016 May;20(38):1-678. doi: 10.3310/hta20380.


Comparing interferon-gamma release assays with tuberculin skin test for identifying latent tuberculosis infection that progresses to active tuberculosis: systematic review and meta-analysis.

Auguste P, Tsertsvadze A, Pink J, Court R, McCarthy N, Sutcliffe P, Clarke A.

BMC Infect Dis. 2017 Mar 9;17(1):200. doi: 10.1186/s12879-017-2301-4. Review.


Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update.

Pai M, Zwerling A, Menzies D.

Ann Intern Med. 2008 Aug 5;149(3):177-84. Epub 2008 Jun 30. Review.


Different screening strategies (single or dual) for the diagnosis of suspected latent tuberculosis: a cost effectiveness analysis.

Pooran A, Booth H, Miller RF, Scott G, Badri M, Huggett JF, Rook G, Zumla A, Dheda K.

BMC Pulm Med. 2010 Feb 22;10:7. doi: 10.1186/1471-2466-10-7.


The Clinical Usefulness of Tuberculin Skin Test versus Interferon-Gamma Release Assays for Diagnosis of Latent Tuberculosis in HIV Patients: A Meta-Analysis.

Ayubi E, Doosti-Irani A, Sanjari Moghaddam A, Sani M, Nazarzadeh M, Mostafavi E.

PLoS One. 2016 Sep 13;11(9):e0161983. doi: 10.1371/journal.pone.0161983. eCollection 2016. Erratum in: PLoS One. 2016 Oct 18;11(10 ):e0165143.


Comparison of two gamma interferon release assays and tuberculin skin testing for tuberculosis screening in a cohort of patients with rheumatic diseases starting anti-tumor necrosis factor therapy.

Vassilopoulos D, Tsikrika S, Hatzara C, Podia V, Kandili A, Stamoulis N, Hadziyannis E.

Clin Vaccine Immunol. 2011 Dec;18(12):2102-8. doi: 10.1128/CVI.05299-11. Epub 2011 Oct 12.


Tuberculin skin testing and treatment modulates interferon-gamma release assay results for latent tuberculosis in migrants.

O'Shea MK, Fletcher TE, Beeching NJ, Dedicoat M, Spence D, McShane H, Cunningham AF, Wilson D.

PLoS One. 2014 May 9;9(5):e97366. doi: 10.1371/journal.pone.0097366. eCollection 2014.


Interferon-gamma release assays versus tuberculin skin testing for detection of latent tuberculosis in chronic haemodialysis patients.

Triverio PA, Bridevaux PO, Roux-Lombard P, Niksic L, Rochat T, Martin PY, Saudan P, Janssens JP.

Nephrol Dial Transplant. 2009 Jun;24(6):1952-6. doi: 10.1093/ndt/gfn748. Epub 2009 Jan 22.


Diagnosing latent tuberculosis infection in the HIV era.

Lagrange PH, Herrmann JL.

Open Respir Med J. 2008;2:52-9. doi: 10.2174/1874306400802010052. Epub 2008 May 23.


Interferon-γ release assays and tuberculin skin testing for diagnosis of latent tuberculosis infection in healthcare workers in the United States.

Dorman SE, Belknap R, Graviss EA, Reves R, Schluger N, Weinfurter P, Wang Y, Cronin W, Hirsch-Moverman Y, Teeter LD, Parker M, Garrett DO, Daley CL; Tuberculosis Epidemiologic Studies Consortium.

Am J Respir Crit Care Med. 2014 Jan 1;189(1):77-87. doi: 10.1164/rccm.201302-0365OC.


[Evolution of IGRA researches].

Ariga H, Harada N.

Kekkaku. 2008 Sep;83(9):641-52. Review. Japanese.


Contribution of interferon-γ release assays (IGRAs) to the diagnosis of latent tuberculosis infection after renal transplantation.

Hadaya K, Bridevaux PO, Roux-Lombard P, Delort A, Saudan P, Martin PY, Janssens JP.

Transplantation. 2013 Jun 27;95(12):1485-90. doi: 10.1097/TP.0b013e3182907073.


Cost-effectiveness of Quantiferon®-TB Gold-in-Tube versus tuberculin skin testing for contact screening and treatment of latent tuberculosis infection in Brazil.

Steffen RE, Caetano R, Pinto M, Chaves D, Ferrari R, Bastos M, de Abreu ST, Menzies D, Trajman A.

PLoS One. 2013 Apr 4;8(4):e59546. doi: 10.1371/journal.pone.0059546. Print 2013.


Interferon-gamma release assays do not identify more children with active tuberculosis than the tuberculin skin test.

Kampmann B, Whittaker E, Williams A, Walters S, Gordon A, Martinez-Alier N, Williams B, Crook AM, Hutton AM, Anderson ST.

Eur Respir J. 2009 Jun;33(6):1374-82. doi: 10.1183/09031936.00153408. Epub 2009 Feb 5.


A three-way comparison of tuberculin skin testing, QuantiFERON-TB gold and T-SPOT.TB in children.

Connell TG, Ritz N, Paxton GA, Buttery JP, Curtis N, Ranganathan SC.

PLoS One. 2008 Jul 9;3(7):e2624. doi: 10.1371/journal.pone.0002624.


Interferon-gamma release assays for the diagnosis of extrapulmonary tuberculosis: a systematic review and meta-analysis.

Fan L, Chen Z, Hao XH, Hu ZY, Xiao HP.

FEMS Immunol Med Microbiol. 2012 Aug;65(3):456-66. doi: 10.1111/j.1574-695X.2012.00972.x. Epub 2012 Jun 18. Review.


Interferon-γ release assays for the diagnosis of Mycobacterium tuberculosis infection in children: a systematic review and meta-analysis.

Chiappini E, Accetta G, Bonsignori F, Boddi V, Galli L, Biggeri A, De Martino M.

Int J Immunopathol Pharmacol. 2012 Jul-Sep;25(3):557-64. Review.


Supplemental Content

Support Center